000			02197 a2200625 4500
005			20250514225032.0
264		0	_c20051122
008			200511s 0 0 eng d
022			_a8756-3282
024	7		_a10.1016/j.bone.2005.03.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aOzasa, Ami
245	0	0	_aComplementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. _h[electronic resource]
260			_bBone _cJun 2005
300			_a1056-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aButadienes _xpharmacology
650	0	4	_aCell Count
650	0	4	_aCell Differentiation
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Size _xdrug effects
650	0	4	_aChondrocytes _xdrug effects
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aFibroblast Growth Factor 2 _xpharmacology
650	0	4	_aFibroblast Growth Factors _xpharmacology
650	0	4	_aFlavonoids _xpharmacology
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aGrowth Plate _xcytology
650	0	4	_aGuanylate Cyclase _xmetabolism
650	0	4	_aHumans
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aMitogen-Activated Protein Kinase 1 _xmetabolism
650	0	4	_aMitogen-Activated Protein Kinase 3 _xmetabolism
650	0	4	_aNatriuretic Peptide, C-Type _xpharmacology
650	0	4	_aNitriles _xpharmacology
650	0	4	_aOrgan Culture Techniques
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aRats
650	0	4	_aReceptor, Fibroblast Growth Factor, Type 3 _xgenetics
650	0	4	_aTibia _xdrug effects
700	1		_aKomatsu, Yasato
700	1		_aYasoda, Akihiro
700	1		_aMiura, Masako
700	1		_aSakuma, Yoko
700	1		_aNakatsuru, Yuko
700	1		_aArai, Hiroshi
700	1		_aItoh, Nobuyuki
700	1		_aNakao, Kazuwa
773	0		_tBone _gvol. 36 _gno. 6 _gp. 1056-64
856	4	0	_uhttps://doi.org/10.1016/j.bone.2005.03.006 _zAvailable from publisher's website
999			_c15536026 _d15536026